申请人:Adir et Compagnie
公开号:US05132305A1
公开(公告)日:1992-07-21
Compounds of general formula (I): ##STR1## in which: R.sub.1 denotes a hydrogen atom or a lower alkyl optionally substituted with a hydroxyl group, R.sub.2 and R.sub.3 : a--identical or different, denote a hydrogen atom, a lower alkyl, a lower alkenyl, a substituted or unsubstituted aryl, a substituted or unsubstituted (lower alkyl)aryl, b--are such that they form, with the nitrogen which carries them, a saturated or unsaturated, mono- or bicyclic heterocyclic system containing at most 3 hetero atoms per ring, substituted or unsubstituted, with the exception of 1-arylpiperazine systems, X denotes a hydrogen atom, Y denotes a hydrogen atom or a hydroxyl, or alternatively X and Y denote an oxygen atom, provided that R.sub.1 is then other than a methyl group, Z denotes a hydrogen atom or forms a .pi. bond with Y, and T denotes a hydrogen atom or a lower alkyl, their stereoisomers and their quaternary ammonium salts, as well as their addition salts with a pharmaceutically acceptable acid.
通式(I)的化合物:##STR1##其中:R.sub.1表示氢原子或一个较低的烷基,可以选择性地取代一个羟基,R.sub.2和R.sub.3:a--相同或不同,表示氢原子,较低的烷基,较低的烯基,取代或未取代的芳基,取代或未取代的(较低的烷基)芳基,b--这样它们与携带它们的氮形成,饱和或不饱和的,单环或双环的杂环系统,每个环最多含有3个杂原子,取代或未取代,除了1-芳基哌嗪系统,X表示氢原子,Y表示氢原子或羟基,或者X和Y表示氧原子,前提是R.sub.1不是甲基基团,则Z表示氢原子或与Y形成.pi.键,T表示氢原子或较低的烷基,它们的立体异构体及其季铵盐,以及它们与药用可接受酸的加合盐。